IO Biotech, Inc.
IOBT
$1.72
$0.010.59%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 28.13M | 37.09M | 60.03M | 80.19M | 100.75M |
| Total Receivables | 1.14M | 922.00K | 1.13M | 964.00K | 1.03M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 639.00K | 960.00K | 1.12M | 252.00K | 651.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 9.07M | 3.37M | 2.67M | 4.84M | 5.22M |
| Total Current Assets | 38.98M | 42.34M | 64.95M | 86.24M | 107.65M |
|
|
|||||
| Total Current Assets | 38.98M | 42.34M | 64.95M | 86.24M | 107.65M |
| Net Property, Plant & Equipment | 2.07M | 2.20M | 2.36M | 2.51M | 2.67M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.27M | 1.19M | 385.00K | 1.19M | 1.14M |
| Total Assets | 42.33M | 45.74M | 67.70M | 89.95M | 111.47M |
|
|
|||||
| Total Accounts Payable | 5.54M | 5.20M | 4.66M | 5.26M | 5.02M |
| Total Accrued Expenses | 13.18M | 11.85M | 13.61M | 9.17M | 7.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 768.00K | 735.00K | 717.00K | 694.00K | 678.00K |
| Total Finance Division Other Current Liabilities | 416.00K | 506.00K | 500.00K | 937.00K | 539.00K |
| Total Other Current Liabilities | 416.00K | 506.00K | 500.00K | 937.00K | 539.00K |
| Total Current Liabilities | 19.90M | 18.29M | 19.49M | 16.06M | 13.72M |
|
|
|||||
| Total Current Liabilities | 19.90M | 18.29M | 19.49M | 16.06M | 13.72M |
| Long-Term Debt | 6.72M | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 868.00K | 1.03M | 1.20M | 1.33M | 1.47M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 13.25M | -- | -- | -- | -- |
| Total Liabilities | 40.73M | 19.31M | 20.68M | 17.38M | 15.20M |
|
|
|||||
| Common Stock & APIC | 416.36M | 414.75M | 413.18M | 411.55M | 409.86M |
| Retained Earnings | -407.95M | -381.73M | -359.31M | -327.98M | -303.97M |
| Treasury Stock & Other | -6.81M | -6.59M | -6.85M | -11.00M | -9.63M |
| Total Common Equity | 1.59M | 26.42M | 47.02M | 72.57M | 96.27M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.59M | 26.42M | 47.02M | 72.57M | 96.27M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.59M | 26.42M | 47.02M | 72.57M | 96.27M |
|
|
|||||